Evidence map›Paper›PMID 32824997›Full record

ArticleMolecules (Basel, Switzerland)2020

Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor.

Wei-Hui Hu, Diana Kun Dai, Brody Zhong-Yu Zheng, Ran Duan, Tina Ting-Xia Dong, Qi-Wei Qin, Karl Wah-Keung Tsim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Dual Effects of Resveratrol on the Expression and Secretion of Angiogenic Factors.International journal of molecular and cellular medicine · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wei-Hui HuJoint Laboratory of Guangdong Province and Hong Kong Region on Marine Bioresource Conservation and Exploitation, College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China.
Diana Kun DaiShenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology, Hi-Tech Park, Nanshan, Shenzhen 518057, China.
Brody Zhong-Yu ZhengShenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology, Hi-Tech Park, Nanshan, Shenzhen 518057, China.
Ran DuanShenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology, Hi-Tech Park, Nanshan, Shenzhen 518057, China.
Tina Ting-Xia DongShenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology, Hi-Tech Park, Nanshan, Shenzhen 518057, China.
Qi-Wei QinJoint Laboratory of Guangdong Province and Hong Kong Region on Marine Bioresource Conservation and Exploitation, College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China.
Karl Wah-Keung TsimShenzhen Key Laboratory of Edible and Medicinal Bioresources, The Hong Kong University of Science and Technology, Hi-Tech Park, Nanshan, Shenzhen 518057, China.
Hong Kong University of Science and Technology · HKSouth China Agricultural University · CN

Funding

China Post-doctoral Science Foundation 2019M653087Guangzhou Science and Technology Committee Research Grant GZSTI16SC02; GZSTI17SC02Hong Kong Innovation Technology Fund UIM/340, UIM/385, ITS/500/18FP; TCPD/17-9Hong Kong RGC Theme-based Research Scheme T13-607/12RShenzhen Science and Technology Innovation Committee ZDSYS201707281432317; JCYJ20170413173747440; JCYJ20180306174903174TUYF19SC02, PD18SC01 HMRF18SC06.Zhongshan Municipal Bureau of Science and Technology ZSST20SC03
6 · The paper itself

Abstract

Piceatannol is also named as

Indexed as

Angiogenesis InhibitorsAnimalsCell ProliferationHumansHuman Umbilical Vein Endothelial CellsNeovascularization, PhysiologicPhosphorylationProtein BindingReceptors, Vascular Endothelial Growth FactorSignal TransductionStilbenesVascular Endothelial Growth Factor AZebrafish3,3',4,5'-tetrahydroxystilbeneAngiogenesis InhibitorsReceptors, Vascular Endothelial Growth FactorStilbenesVascular Endothelial Growth Factor AVEGFA protein, humanherbal medicinepiceatannolpure compoundvasculogenesisVEGFVEGFR2

Identifiers

PMID32824997
PMCPMC7504081
OpenAlexW3060019369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.